The effect of terpene concentrations on the skin penetration of diclofenac sodium

International Journal of Pharmaceutics

Volumn 335, Issue 1-2, 2007, Pages 97-105

  Nokhodchi, A ^a   Sharabiani, K ^b   Rashidi, M R ^b   Ghafourian, T ^a,b  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diclofenac sodium; Enhancer; log P; Skin permeation; Terpenes

Indexed keywords

CARVONE; DICLOFENAC; EXCIPIENT; FARNSOL; LIMONENOXIDE; MENTHONE; NEROLIDOL; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG SOLUBILITY; DRUG TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PENETRATION; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FARNESOL; GLYCEROL; MALE; MENTHOL; MOLECULAR STRUCTURE; MONOTERPENES; ORGAN CULTURE TECHNIQUES; PERMEABILITY; RATS; RATS, WISTAR; SESQUITERPENES; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLVENTS; TERPENES;

EID: 33947606082     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.10.041     Document Type: Article

References (47)

1. Arellano A., Santoyo S., Martin C., and Ygartua P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm. 130 (1996) 141-145
2. Ashton P., Hadgraft J., and Walters K.A. Effect of surfactants in percutaneous absorption. Pharm. Acta Helv. 61 (1986) 228-235
3. Barry B.W. Dermatological Formulations: Percutaneous Absorption (1983), Marcel Dekker, New York
4. Berner B., Mazzenga G.C., Otte J.H., Steffens R.J., Juang R.H., and Ebert C.D. Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin. J. Pharm. Sci. 78 (1989) 402-407
5. Cornwell P.A., and Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 46 (1991) 261-269
6. El-Kattan A.F., Asbill C.S., and Michniak B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 198 (2000) 179-189
7. Fang J.Y., Hwang T.L., and Leu Y.L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int. J. Pharm. 250 (2003) 313-325
8. Friend D., Catz P., Heller J., Reid J., and Baker R. Transdermal delivery of levonorgestrel I. Alkanols as permeation enhancers. J. Controlled Release 7 (1988) 243-250
9. Gao S., and Singh J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifien by terpenes. J. Controlled Release 51 (1998) 193-199
10. Ghafourian T., Hamishkar H., Zandasrar P., and Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study Skin QSAR. J. Controlled Release 99 (2004) 113-125
11. Goodman M., and Barry B.W. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and oestradiol: I. Infinite dose technique. J. Invest. Dermatol. 91 (1988) 323-327
12. Hori M., Satoh S., Maibach H.I., and Gug R.H. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 80 (1991) 32-35
13. Jain A.K., Thomas N.S., and Panchagnula R. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J. Controlled Release 79 (2002) 93-101
14. Komata Y., Inoaka M., Kaneko A., and Fujie T. In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J. Pharm. Sci. 81 (1992) 744-746
15. Kunta J.R., Goskonda V.R., Brotherton H.O., Khan M.A., and Reddy I. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86 (1997) 1369-1373
16. Kurihara-Begstrom T., Flynn G.I., and Higuchi W.I. Physicochemical study of percutaneous-absorption enhancement by dimethylsufoxide mediation of vidarabine (Ara-A) permeation of hairless mouse skin. J. Invest. Dermatol. 89 (1987) 274-280
17. Kurihara-Bergstrom T., Knutson K., De Noble L.J., and Goates C.Y. Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm. Res. 7 (1990) 762-766
18. Iwasa A., Irimoto K., Kasai S., Okuyama H., and Nagai T. Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaaku 51 (1991) 16-21
19. Manasse R., Hedwall P.R., Kraetz J., Pericin C., Riesterer J., Sallmann A., Ziel R., and Jaques R. Pharmacological properties of diclofenac sodium aand its metabolites. Scand. J. Rheumatol. Suppl. 22 (1978) 5-16
20. Megrab N.A., Williams A.C., and Barry B.W. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int. J. Pharm. 116 (1995) 101-112
21. Moghimi H., Williams A., and Barry B.W. A lamellar matrix for stratum corneum intercellular lipids. IV. Effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int. J. Pharm. 145 (1996) 49-59
22. Moghimi H., Williams A., and Barry B.W. A lamellar matrix for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int. J. Pharm. 146 (1997) 41-54
23. Moghimi H.R., Williams A.C., and Barry B.W. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J. Pharm. Pharmacol. 50 (1998) 955-964
24. Naito S., and Tominagaa H. Percutaneous absorption of diclofenac sodium ointment. Int. J. Pharm. 24 (1985) 115-124
25. Nishihata T., Kamada A., Sakai K., Takahashi K., Matsumoto K., Shinozaki K., Tabata Y., Keigami M., Miyagi T., and Tatsumi N. Percutanouse absorption of diclofenac in rat and humans: aqueous gel formulation. Int. J. Pharm. 46 (1988) 1-7
26. Nishihata T., Kotera K., Nakano Y., and Yamazaki M. Rat percutaneous transport of diclofenac and influence of hydrogenated soya lecithin. Chem. Pharm. Bull. 35 (1987) 3807-3812
27. Nokhodchi A., Nazemiyeh H., Ghafourian T., Hassan-Zadeh D., Valizadeh H., and Bahary L.A.S. The effect of glycerrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Il Farmaco 57 (2002) 883-888
28. Nokhodchi A., Shokri J., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., and Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm. 250 (2003) 359-369
29. Obata Y.T. Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Des. Deliv. 8 (1991) 137-144
30. Obata Y., Takayama M., Maitani Y., Machida Y., and Nagai T. Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm. 89 (1993) 191-198
31. Okabe H., Takayama K., Ogura A., and Nagai T. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Deliv. 4 (1989) 313-321
32. Okabe H., Obata Y., Takayama K., and Nagai T. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des. Deliv. 6 (1990) 229
33. Opdyke D. Monographs on fragrance raw materials. Food Cosmet. Toxicol. 1 (1979) 11-17
34. Pershing L.K., Lambert L.D., and Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 7 (1990) 170-175
35. Pfister W., Dean S., and hsieh S. Permeation enhancers compatible with transdermal drug delivery systems. I. Selection and formulation considerations. Pharm. Tech. 8 (1990) 132-140
36. Santoyo S., Arellano A., Ygartua Y., and Martin C. Penetration enhancer effects on the invitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm. 117 (1995) 509-511
37. Shokri J., Nokhodchi A., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., and Barzegar-Jalali M. The effect of surfactants on the skin penetration of diazepam. Int. J. Pharm. 228 (2001) 99-107
38. Takahashi K., Tamagawa S., Katagi T., Yoshitomi H., Kamada H., Rytting J., Iwasa A., Irimoto K., Kasai S., Okuyama H., and Nagai T. Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaaku 51 (1991) 16-21
39. Takahashi K., Tamagawa S., Katagi T., Yoshitomi H., Kamada A., Rytting J., Nishihata T., and Mizuno N. In vitro percutaneous transport of sodium diclofenac and diclofenac from oleaginous vehicle. Chem. Pharm. Bull. 39 (1991) 509-511
40. Thomas N.S., and Panchagnula R. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Pharm. Sci. 18 (2003) 71-79
41. Tsuzuki N., Wong O., and Higuchi T. Effect of primary alcohols on percutaneous-absorption. Int. J. Pharm. 46 (1988) 19-23
42. Williams A.C., and Barry B.W. Essential oils as novel human skin penetration enhancers. Int. J. Pharm. 57 (1989) R7-R9
43. Williams A.C., and Barry B.W. Terpenes and the lipid protein partitioning theory of skin penetration enhancement. Pharm. Res. 8 (1991) 17-24
44. Woolfson A.D., Malcolm R.K., Campbell K., Jones D.S., and Russell J.A. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J. Controlled Release 67 (2000) 395-408
45. Wong O., Tsuzuki N., Nghiem B., Kuehnhoff J., Itoh T., Masaki K., Huntington J., Konishi R., Rytting J.H., and Higuchi T. Unsaturated cyclic areas as new non-toxic biodegradable transdermal permeation enhancers. 2. Evaluation study. Int. J. Pharm. 52 (1989) 191-201
46. Yamane M.A., Williams A.C., and Barry B.W. Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int. J. Pharm. 116 (1995) 237-251
47. Yasukawa, T., Akiyoshi, Y., Hattori, A., Harada, S. Anti-inflamatory topical formulations containing indomethacin and diclofenac. Jpn. Kokai Tokkio Koho JP 60146823 A2, Aug. 22nd, 1985.